The receptor tyrosine kinase Mer promotes multiple myeloma progression and osteolytic bone disease

被引：0

作者：

Engelmann, J. ^{[1
,2
]}

Ben Batalla, I. ^{[1
,2
]}

Taipaleenmaeki, H. ^{[3
]}

Riecken, K. ^{[4
]}

Gensch, V. ^{[1
,2
]}

Paesler, S. ^{[1
,2
]}

Berenbrok, N. ^{[1
,2
]}

Vargas, M. E. ^{[1
,2
]}

Waizenegger, J. ^{[2
]}

Fehse, B. ^{[4
]}

Pantel, K. ^{[2
]}

Darwish, I. ^{[5
]}

Bhamidipati, S. ^{[5
]}

Masuda, E. ^{[5
]}

Bokemeyer, C. ^{[1
]}

Hesse, E. ^{[3
]}

Loges, S. ^{[1
,2
]}

机构：

[1] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 2, Abt Pneumol, Onkol,Hamatol,Knochenmarktransplantat, Hamburg, Germany

[2] Univ Klinikum Hamburg Eppendorf, Inst Tumorbiol, Hamburg, Germany

[3] Univ Klinikum Hamburg Eppendorf, Expt Unfallchirurg, Heisenberg Arbeitsgrp, Hamburg, Germany

[4] Univ Klinikum Hamburg Eppendorf, Interdisziplinare Klin & Poliklin Stammzelltransp, Hamburg, Germany

[5] Rigel Pharmaceut Inc, San Francisco, CA USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P708

引用

页码：190 / 190

页数：1

共 50 条

[1] Mer Receptor Tyrosine Kinase Is a Novel Therapeutic Target In Multiple Myeloma
Christoph, Sandra
Maag, Silks
DeRyckere, Deborah
Graham, Douglas K.
Frye, Stephen V.
Earp, H. Shelton, III
Liu, Jing
Yang, Chao
Zhang, Weihe
Wang, Xiaodong
Elmaagacli, Ahmet H.
Beelen, Dietrich
BLOOD, 2013, 122 (21)
[2] Threonine and tyrosine kinase promotes multiple myeloma progression by regulating regucalcin expression
Zhu, Xiaofeng
Feng, Zuxi
Peng, Xiaohuan
Di, Tianning
Li, Yanhong
Bai, Jun
Ma, Tao
Li, Lijuan
Zhang, Liansheng
EXPERIMENTAL CELL RESEARCH, 2025, 446 (02)
[3] SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
Heusschen, Roy
Muller, Josephine
Binsfeld, Marilene
Marty, Caroline
Plougonven, Erwan
Dubois, Sophie
Mahli, Nadia
Moermans, Karen
Carmeliet, Geert
Leonard, Angelique
Baron, Frederic
Beguin, Yves
Menu, Eline
Cohen-Solal, Martine
Caers, Jo
ONCOTARGET, 2016, 7 (21) : 30712 - 30729
[4] A role for immunoglobulins in the osteolytic bone disease of multiple myeloma
Westhrin, Marita
Kovcic, Vlado
Bondt, Albert
Holst, Stephanie
Zhang, Zeijan
Slordahl, Tobias
Sundan, Anders
Waage, Anders
Wuhrer, Manfred
Standal, Therese
JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 341 - 341
[5] Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme
Wang, Y.
Moncayo, G.
Morin, P., Jr.
Xue, G.
Grzmil, M.
Lino, M. M.
Clement-Schatlo, V.
Frank, S.
Merlo, A.
Hemmings, B. A.
ONCOGENE, 2013, 32 (07) : 872 - 882
[6] Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme
Y Wang
G Moncayo
P Morin
G Xue
M Grzmil
M M Lino
V Clément-Schatlo
S Frank
A Merlo
B A Hemmings
Oncogene, 2013, 32 : 872 - 882
[7] Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Croucher, PI
Shipman, CM
Perry, M
Lippitt, J
Asosingh, K
van Beek, EJR
Van Camp, B
Russell, RGG
Dunstan, C
Vanderkerken, K
BONE, 2001, 28 (05) : S81 - S81
[8] LIGHT INVOLVEMENT IN MULTIPLE MYELOMA-OSTEOLYTIC BONE DISEASE
Brunetti, G.
Rizzi, R.
Gigante, I.
Oranger, A.
Mori, G.
Carbone, C.
Mongelli, T.
Scardino, S.
Daraia, B.
Curci, P.
Mestice, A.
Zallone, A.
Colucci, S.
Specchia, G.
Grano, M.
HAEMATOLOGICA, 2014, 99 : 628 - 629
[9] Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Croucher, PI
Shipman, CM
Lippitt, J
Perry, M
Asosingh, K
Hijzen, A
Brabbs, AC
van Beek, EJR
Holen, I
Skerry, TM
Dunstan, CR
Russell, GR
Van Camp, B
Vanderkerken, K
BLOOD, 2001, 98 (13) : 3534 - 3540
[10] Heparanase Promotes the Osteolytic Phenotype in Multiple Myeloma
Yang, Yang
Ritchie, Joseph P.
Suva, Larry J.
Sanderson, Ralph D.
BLOOD, 2008, 112 (11) : 311 - 312

← 1 2 3 4 5 →